Emerging technology with artificial intelligence is fine-tuning the treatment of breast cancer by identifying sub-types of breast cancer to customize treatment plans. These developments will be applied to other forms of cancer diagnosis and to study the evolution of cancer and drug resistance in treatment today.
Posted by Rebecca Harris
Rebecca Moody Harris is a CPA and CFO with over eighteen years of progressive financial experience. For the last twelve years, she has served the healthcare industry in CFO and executive leadership roles. Her experience ranges from large corporations to start-ups in the private sector, and Rebecca specializes in Mergers and Acquisitions, Private Equity fundraising, and computer information systems.
